Stay updated on MUKnineb: OPTIMUM Treatment Protocol Clinical Trial
Sign up to get notified when there's something new on the MUKnineb: OPTIMUM Treatment Protocol Clinical Trial page.

Latest updates to the MUKnineb: OPTIMUM Treatment Protocol Clinical Trial page
- Check4 days agoChange DetectedAn NIH notice announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology. The page continues to show a 403 error instead of the study record, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on the page displaying a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedPreviously, the page showed a 403 Forbidden error, blocking access to the study record. The error page content was removed, and the study details are now accessible.SummaryDifference0.5%

- Check32 days agoChange DetectedThe page now displays a 403 Forbidden error page, replacing the prior study details with a generic error screen. The layout includes the standard site header/footer around the 403 message, indicating the content is inaccessible.SummaryDifference21%

- Check39 days agoChange DetectedA new publication citation for OPTIMUM/MUKnine's 5-year follow-up in Lancet Oncology was added to Publications, and the Revision: v3.7.0 tag was introduced. Related topics such as MedlinePlus Genetics and the 'Multiple myeloma' topic were removed.SummaryDifference0.2%

- Check46 days agoChange DetectedAdded related topics entries: 'Multiple myeloma' and a 'MedlinePlus Genetics' link under the Related Topics section, expanding educational references for this trial.SummaryDifference0.1%

Stay in the know with updates to MUKnineb: OPTIMUM Treatment Protocol Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MUKnineb: OPTIMUM Treatment Protocol Clinical Trial page.